PL3639849T3 - Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń - Google Patents
Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świńInfo
- Publication number
- PL3639849T3 PL3639849T3 PL19192963.7T PL19192963T PL3639849T3 PL 3639849 T3 PL3639849 T3 PL 3639849T3 PL 19192963 T PL19192963 T PL 19192963T PL 3639849 T3 PL3639849 T3 PL 3639849T3
- Authority
- PL
- Poland
- Prior art keywords
- affican
- fever virus
- swine fever
- based vaccine
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12061—Methods of inactivation or attenuation
- C12N2710/12062—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1410971.4A GB201410971D0 (en) | 2014-06-19 | 2014-06-19 | Vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3639849T3 true PL3639849T3 (pl) | 2025-11-24 |
Family
ID=51409865
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19192963.7T PL3639849T3 (pl) | 2014-06-19 | 2015-06-19 | Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń |
| PL15733494T PL3157550T3 (pl) | 2014-06-19 | 2015-06-19 | Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15733494T PL3157550T3 (pl) | 2014-06-19 | 2015-06-19 | Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10507237B2 (pl) |
| EP (2) | EP3157550B1 (pl) |
| CN (1) | CN106459931B (pl) |
| AP (1) | AP2016009664A0 (pl) |
| EA (1) | EA035441B1 (pl) |
| ES (2) | ES2750960T3 (pl) |
| GB (1) | GB201410971D0 (pl) |
| HU (1) | HUE045815T2 (pl) |
| PL (2) | PL3639849T3 (pl) |
| UA (1) | UA121217C2 (pl) |
| WO (1) | WO2015193685A1 (pl) |
| ZA (1) | ZA201608257B (pl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201410971D0 (en) | 2014-06-19 | 2014-08-06 | Pirbright Inst The | Vaccine |
| RU2607791C1 (ru) * | 2016-01-21 | 2017-01-10 | Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Российской академии сельскохозяйственных наук | Аттенуированный штамм "СКА-2015 ВНИИВВиМ" вируса африканской чумы свиней VIII серотипа для вирусологических и молекулярно-генетических исследований |
| US9808520B1 (en) * | 2016-07-01 | 2017-11-07 | The United States Of America As Represented By The Secretary Of Agriculture | Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate |
| WO2020049194A1 (es) * | 2018-09-03 | 2020-03-12 | Universidad Complutense De Madrid (Ucm) | Virus vacunal sus scrofa frente a la peste porcina africana (armenia/07) y derivados del genotipo ii) |
| EP3946445A2 (en) | 2019-03-27 | 2022-02-09 | Boehringer Ingelheim Vetmedica GmbH | Immunogenic compositions and vaccines comprising african swine fever virus peptides and proteins and uses thereof |
| CN110093324B (zh) * | 2019-04-26 | 2020-02-18 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 基因缺失的减毒非洲猪瘟病毒及其作为疫苗的应用 |
| PH12021551677A1 (en) | 2019-04-26 | 2022-03-21 | Harbin Veterinary Res Institute Chinese Academy Of Agricultural Sciences | Attenuated african swine fever virus with deleted gene and use of same as vaccine |
| CN111926110B (zh) * | 2019-05-31 | 2021-04-27 | 洛阳普泰生物技术有限公司 | 非洲猪瘟病毒实时荧光pcr扩增引物对、探针引物、及制备的试剂盒 |
| KR20220042369A (ko) * | 2019-07-11 | 2022-04-05 | 앱티뮨 바이올로직스, 인코포레이티드 | 태아 돼지 폐 폐포 마크로파지 세포에서 아프리카 돼지 열병 바이러스를 성장시키기 위한 방법 |
| GB201910794D0 (en) * | 2019-07-29 | 2019-09-11 | Pirbright Inst | Vaccine |
| CN110551695A (zh) * | 2019-08-14 | 2019-12-10 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 非洲猪瘟病毒四基因缺失弱毒株及其应用 |
| CN110499394A (zh) * | 2019-09-10 | 2019-11-26 | 延安大学 | 检测非洲猪瘟病毒的lamp引物组、试剂盒及检测方法 |
| JP7382628B2 (ja) * | 2019-10-11 | 2023-11-17 | 国立研究開発法人農業・食品産業技術総合研究機構 | アフリカ豚コレラウイルスの製造方法及び検出方法 |
| CN110878377B (zh) * | 2019-11-06 | 2023-08-22 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 非洲猪瘟病毒强弱毒荧光定量pcr鉴别诊断试剂盒 |
| CN110699489B (zh) * | 2019-11-12 | 2020-12-22 | 南宁众册生物科技有限公司 | 非洲猪瘟病毒cd2v基因的实时荧光pcr检测引物探针组、试剂盒及方法 |
| CN110791591B (zh) * | 2019-11-18 | 2023-06-23 | 华南农业大学 | 一种区分非洲猪瘟病毒野毒株与双基因缺失疫苗株的lamp检测引物及试剂盒 |
| CN112831598B (zh) * | 2019-11-22 | 2022-12-20 | 洛阳普泰生物技术有限公司 | 用于非洲猪瘟病毒鉴别检验的实时荧光pcr扩增引物对、探针引物、及制备的试剂盒 |
| CN113122654A (zh) * | 2019-12-30 | 2021-07-16 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 非洲猪瘟病毒的检测靶标以及荧光定量pcr检测引物 |
| JP2023516713A (ja) * | 2020-03-06 | 2023-04-20 | ザ パーブライト インスティチュート | アフリカ豚熱ウイルス感染に対するワクチン |
| CN111593028A (zh) * | 2020-04-15 | 2020-08-28 | 中国农业科学院兰州兽医研究所 | 一种缺失mgf360-9l基因的非洲猪瘟病毒减毒株及其应用 |
| CN112063634A (zh) * | 2020-05-01 | 2020-12-11 | 中国农业科学院兰州兽医研究所 | 一种基因缺失的减毒非洲猪瘟病毒株及应用 |
| CN111748563A (zh) * | 2020-07-10 | 2020-10-09 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟基因缺失弱毒株的构建及其作为疫苗的应用 |
| CN111676327B (zh) * | 2020-07-21 | 2021-05-14 | 河南省农业科学院 | 非洲猪瘟病毒野毒感染与基因缺失毒株双重荧光定量pcr检测组合物、方法及试剂盒 |
| CN113929746B (zh) * | 2020-08-26 | 2023-07-25 | 中国农业科学院兰州兽医研究所 | 一类促进猪机体产生广谱性免疫应答的多肽及其应用 |
| CN111925996A (zh) * | 2020-08-27 | 2020-11-13 | 军事科学院军事医学研究院军事兽医研究所 | 一种非洲猪瘟基因缺失减毒及其活疫苗 |
| CN111996175B (zh) * | 2020-09-04 | 2023-11-21 | 军事科学院军事医学研究院军事兽医研究所 | 缺失e66l、i267l基因的非洲猪瘟减毒及活疫苗 |
| US11766476B2 (en) * | 2020-12-22 | 2023-09-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines |
| US20240053340A1 (en) | 2020-12-24 | 2024-02-15 | Intervet Inc. | African swine fever diva immunoassay |
| EP4036226A1 (en) * | 2021-02-02 | 2022-08-03 | Agence Nationale chargée de la Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail | Attenuated african swine fever virus and its use as a vaccine |
| CN113462817A (zh) * | 2021-07-13 | 2021-10-01 | 四川农业大学 | 检测非洲猪瘟病毒衣壳完整性的pcr引物、探针、试剂盒及检测方法 |
| CN114107228B (zh) * | 2021-11-11 | 2023-06-13 | 中国农业科学院兰州兽医研究所 | 缺失十二个基因的减毒非洲猪瘟病毒株的构建及其作为疫苗的应用 |
| CN117701509B (zh) * | 2023-11-20 | 2024-05-28 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一种非洲猪瘟病毒传代致弱毒株与基于该毒株的疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020086427A1 (en) * | 2000-03-23 | 2002-07-04 | Leiden Jeffrey M. | Inducible eukaryotic expression system that regulates protein translation |
| US8133495B2 (en) * | 2007-05-22 | 2012-03-13 | The United States Of America As Represented By The Secretary Of Agriculture | Live attenuated antigenically marked classical swine fever virus |
| CN103172749B (zh) * | 2013-02-01 | 2014-10-08 | 广州谱泰生物技术有限公司 | 一种非洲猪瘟蛋白工程疫苗的制备 |
| GB201410971D0 (en) | 2014-06-19 | 2014-08-06 | Pirbright Inst The | Vaccine |
-
2014
- 2014-06-19 GB GBGB1410971.4A patent/GB201410971D0/en not_active Ceased
-
2015
- 2015-06-19 CN CN201580032193.1A patent/CN106459931B/zh active Active
- 2015-06-19 ES ES15733494T patent/ES2750960T3/es active Active
- 2015-06-19 EP EP15733494.7A patent/EP3157550B1/en active Active
- 2015-06-19 US US15/319,856 patent/US10507237B2/en active Active
- 2015-06-19 AP AP2016009664A patent/AP2016009664A0/en unknown
- 2015-06-19 EP EP19192963.7A patent/EP3639849B1/en active Active
- 2015-06-19 WO PCT/GB2015/051798 patent/WO2015193685A1/en not_active Ceased
- 2015-06-19 ES ES19192963T patent/ES3046674T3/es active Active
- 2015-06-19 UA UAA201700461A patent/UA121217C2/uk unknown
- 2015-06-19 EA EA201692509A patent/EA035441B1/ru unknown
- 2015-06-19 PL PL19192963.7T patent/PL3639849T3/pl unknown
- 2015-06-19 HU HUE15733494A patent/HUE045815T2/hu unknown
- 2015-06-19 PL PL15733494T patent/PL3157550T3/pl unknown
-
2016
- 2016-11-29 ZA ZA2016/08257A patent/ZA201608257B/en unknown
-
2019
- 2019-10-30 US US16/668,384 patent/US11331383B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE045815T2 (hu) | 2020-01-28 |
| ZA201608257B (en) | 2024-04-24 |
| GB201410971D0 (en) | 2014-08-06 |
| EP3157550A1 (en) | 2017-04-26 |
| EA201692509A1 (ru) | 2017-05-31 |
| UA121217C2 (uk) | 2020-04-27 |
| PL3157550T3 (pl) | 2020-03-31 |
| EP3157550B1 (en) | 2019-08-28 |
| AP2016009664A0 (en) | 2016-12-31 |
| CN106459931B (zh) | 2020-10-13 |
| US11331383B2 (en) | 2022-05-17 |
| US20170136114A1 (en) | 2017-05-18 |
| EP3639849C0 (en) | 2025-07-30 |
| CN106459931A (zh) | 2017-02-22 |
| US20200129609A1 (en) | 2020-04-30 |
| ES3046674T3 (en) | 2025-12-02 |
| EA035441B1 (ru) | 2020-06-17 |
| ES2750960T3 (es) | 2020-03-30 |
| WO2015193685A1 (en) | 2015-12-23 |
| US10507237B2 (en) | 2019-12-17 |
| EP3639849A1 (en) | 2020-04-22 |
| EP3639849B1 (en) | 2025-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3639849T3 (pl) | Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń | |
| DK3393510T3 (da) | Zikavirusvaccine | |
| DK4023249T3 (da) | Nukleinsyrevacciner | |
| LT3718565T (lt) | Kvėpavimo takų virusų vakcinos | |
| EP3659614C0 (en) | ONCOLYTIC VACCINIA VIRUS | |
| EP3207483C0 (en) | ANCESTRAL HUMAN GENOMES | |
| DK3218504T3 (da) | Trisegmenterede arenavira som vaccinevektorer | |
| HUE040440T2 (hu) | Terápiás HPV16-oltóanyagok | |
| EP2958994A4 (en) | Vaccine composition | |
| HUE063036T2 (hu) | Orális rehidráló készítmény | |
| IL249823A0 (en) | Meningococcus vaccines | |
| EP3273989C0 (en) | STREPTOCOCCAL VACCINE | |
| EP3632350C0 (en) | EMBOLIZATION DEVICE | |
| CL2016002146A1 (es) | Plásmidos inmunoestimuladores | |
| DK3129007T3 (da) | Vaccinesammensætninger | |
| EP3560512A4 (en) | COMPOSITION OF VACCINE AGAINST ZONA | |
| DK3062824T3 (da) | Telomerase-kodende dna-vaccine | |
| SI3188599T1 (sl) | Zdravljenje na osnovi anamorelina | |
| DK2952231T3 (da) | Ketsjer | |
| HUE056414T2 (hu) | Triptofán-2,3-dioxigenázt vagy annak fragmentumait tartalmazó vakcinakészítmények | |
| EP3562498A4 (en) | INFLUENZA VACCINES | |
| DK3155004T3 (da) | Vaccine til immunkompromitterede værter | |
| DK2958935T3 (da) | Vaccine | |
| HUE047581T2 (hu) | Készítmény | |
| DK3193923T3 (da) | Adjuvanser |